The associations between a polygenic score, reproductive and menstrual risk factors and breast cancer risk

被引:0
|
作者
Shaneda Warren Andersen
Amy Trentham-Dietz
Ronald E. Gangnon
John M. Hampton
Jonine D. Figueroa
Halcyon G. Skinner
Corinne D. Engelman
Barbara E. Klein
Linda J. Titus
Polly A. Newcomb
机构
[1] University of Wisconsin Carbone Cancer Center,Department of Population Health Sciences
[2] University of Wisconsin School of Medicine and Public Health,Division of Cancer Epidemiology & Genetics
[3] National Cancer Institute,Department of Ophthalmology and Visual Sciences
[4] University of Wisconsin School of Medicine and Public Health,Norris Cotton Cancer Center
[5] Dartmouth Medical School,Cancer Prevention Program
[6] Fred Hutchinson Cancer Research Center,undefined
来源
关键词
Epidemiology; Reproductive and menstrual factors; Breast cancer; Breast cancer susceptibility loci;
D O I
暂无
中图分类号
学科分类号
摘要
We evaluated whether 13 single nucleotide polymorphisms (SNPs) identified in genome-wide association studies interact with one another and with reproductive and menstrual risk factors in association with breast cancer risk. DNA samples and information on parity, breastfeeding, age at menarche, age at first birth, and age at menopause were collected through structured interviews from 1,484 breast cancer cases and 1,307 controls who participated in a population-based case–control study conducted in three US states. A polygenic score was created as the sum of risk allele copies multiplied by the corresponding log odds estimate. Logistic regression was used to test the associations between SNPs, the score, reproductive and menstrual factors, and breast cancer risk. Nonlinearity of the score was assessed by the inclusion of a quadratic term for polygenic score. Interactions between the aforementioned variables were tested by including a cross-product term in models. We confirmed associations between rs13387042 (2q35), rs4973768 (SLC4A7), rs10941679 (5p12), rs2981582 (FGFR2), rs3817198 (LSP1), rs3803662 (TOX3), and rs6504950 (STXBP4) with breast cancer. Women in the score’s highest quintile had 2.2-fold increased risk when compared to women in the lowest quintile (95 % confidence interval: 1.67–2.88). The quadratic polygenic score term was not significant in the model (p = 0.85), suggesting that the established breast cancer loci are not associated with increased risk more than the sum of risk alleles. Modifications of menstrual and reproductive risk factors associations with breast cancer risk by polygenic score were not observed. Our results suggest that the interactions between breast cancer susceptibility loci and reproductive factors are not strong contributors to breast cancer risk.
引用
收藏
页码:427 / 434
页数:7
相关论文
共 50 条
  • [31] Performance of a polygenic risk score combined with clinical assessment for breast cancer risk
    Black, Mary Helen
    Li, Shuwei
    LaDuca, Holly
    Armasu, Sebastian
    Polley, Eric C.
    Fitz-Gibbon, Patrick
    Scott, Chris G.
    Winham, Stacey J.
    Olson, Janet E.
    Ruddy, Kathryn J.
    Vachon, Celine M.
    Couch, Fergus J.
    CANCER RESEARCH, 2020, 80 (04)
  • [32] Polygenic risk score, stage, and mode of detection in relation to breast cancer risk
    Trentham-Dietz, Amy
    Hampton, John M.
    Ong, Irene M.
    Page, C. David
    Gould, Michael N.
    Haag, Jill D.
    Newcomb, Polly A.
    Shull, James D.
    Burnside, Elizabeth S.
    CANCER RESEARCH, 2018, 78 (13)
  • [33] Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification
    Olsen, Maria
    Fischer, Krista
    Bossuyt, Patrick M.
    Goetghebeur, Els
    BMC CANCER, 2021, 21 (01)
  • [34] Polygenic risk score for breast cancer in high-risk women.
    Black, Mary Helen
    Li, Shuwei
    LaDuca, Holly
    Chen, Jefferey
    Hoiness, Robert
    Gutierrez, Stephanie
    Lu, Hsiao-Mei
    Dolinsky, Jill S.
    Xu, Jianfeng
    Vachon, Celine
    Couch, Fergus
    Davis, Brigette Tippin
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [35] Development and Validation of a Clinical Polygenic Risk Score to Predict Breast Cancer Risk
    Hughes, Elisha
    Tshiaba, Placede
    Gallagher, Shannon
    Wagner, Susanne
    Judkins, Thaddeus
    Roa, Benjamin
    Rosenthal, Eric
    Domchek, Susan
    Garber, Judy
    Lancaster, Johnathan
    Weitzel, Jeffrey
    Kurian, Allison W.
    Lanchbury, Jerry S.
    Gutin, Alexander
    Robson, Mark
    JCO PRECISION ONCOLOGY, 2020, 4 : 585 - 592
  • [36] Toward more personalized breast cancer risk assessment: The polygenic risk score
    Sarkis-Tannous, Daad
    Sukol, Roxanne B.
    Sullivan, Erika
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2023, 36 (10): : 37 - 40
  • [37] Utilizing polygenic risk score for breast cancer risk prediction in a Taiwanese population
    Lin, Yi-Hsuan
    Hung, Chih-Chiang
    Lin, Guan-Cheng
    Tsai, I. -Chen
    Lum, Chih Yean
    Hsiao, Tzu-Hung
    CANCER EPIDEMIOLOGY, 2025, 94
  • [38] MENSTRUAL FACTORS AND RISK OF BREAST-CANCER
    BRINTON, LA
    SCHAIRER, C
    HOOVER, RN
    FRAUMENI, JF
    CANCER INVESTIGATION, 1988, 6 (03) : 245 - 254
  • [39] Menstrual factors in relation to breast cancer risk
    Titus-Ernstoff, L
    Longnecker, MP
    Newcomb, PA
    Dain, B
    Greenberg, ER
    Mittendorf, R
    Stampfer, M
    Willett, W
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1998, 7 (09) : 783 - 789
  • [40] MENSTRUAL FACTORS AND BREAST-CANCER RISK
    KVALE, G
    HEUCH, I
    CANCER, 1988, 62 (08) : 1625 - 1631